Open access
Open access
Powered by Google Translator Translator

Covid-19

Long covid—an update for primary care.

23 Sep, 2022 | 13:10h | UTC

Long covid—an update for primary care – The BMJ

 


RCT | Helmet noninvasive ventilation no better than usual respiratory support for acute hypoxemic respiratory failure due to COVID-19.

22 Sep, 2022 | 13:11h | UTC

Effect of Helmet Noninvasive Ventilation vs Usual Respiratory Support on Mortality Among Patients With Acute Hypoxemic Respiratory Failure Due to COVID-19: The HELMET-COVID Randomized Clinical Trial – JAMA

 

Commentary on Twitter

 


Understanding post-COVID-19 interstitial lung disease: a new fibroinflammatory disease entity.

22 Sep, 2022 | 13:09h | UTC

Understanding post-COVID-19 interstitial lung disease (ILD): a new fibroinflammatory disease entity – Intensive Care Medicine

 

Commentary on Twitter

 


The Lancet Commission on lessons for the future from the COVID-19 pandemic – “a massive global failure.”

16 Sep, 2022 | 13:03h | UTC

Homepage: The Lancet COVID-19 Commission

The Lancet Commission on lessons for the future from the COVID-19 pandemic

Editorial: COVID-19: the case for prosociality

News Release: New report details “massive global failures” of COVID-19 response, calls for improved multilateral cooperation to end pandemic and effectively manage future global health threats – The Lancet

Infographic: COVID-19 response: a massive global failure

Commentaries:

WHO responds to The Lancet COVID-19 Commission – World Health Organization

Covid-19: Commission describes “massive global failures” of pandemic response – The BMJ

Covid-19 death toll is a tragedy and ‘massive global failure at multiple levels,’ Lancet commission says – CNN

Lancet Commission on COVID-19 response: ‘Massive global failure’ – CIDRAP

 


Review | Multisystem inflammatory syndrome in children (MIS-C) and neonates (MIS-N) associated with COVID-19: optimizing definition and management.

14 Sep, 2022 | 13:15h | UTC

Multisystem inflammatory syndrome in children (MIS-C) and neonates (MIS-N) associated with COVID-19: optimizing definition and management – Pediatrics Research

 

Commentary on Twitter

Under a http://creativecommons.org/licenses/by/4.0/ License

 


RCT | Anti-C5a antibody (vilobelimab) therapy for critically ill, invasively mechanically ventilated patients with COVID-19.

13 Sep, 2022 | 13:16h | UTC

Anti-C5a antibody (vilobelimab) therapy for critically ill, invasively mechanically ventilated patients with COVID-19 (PANAMO): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial – The Lancet Respiratory Medicine

 

Commentaries on Twitter

 


RCT | Dipeptidyl peptidase-1 inhibition does not improve outcomes in patients hospitalized with COVID-19.

13 Sep, 2022 | 13:15h | UTC

Dipeptidyl peptidase-1 inhibition in patients hospitalised with COVID-19: a multicentre, double-blind, randomised, parallel-group, placebo-controlled trial – The Lancet Respiratory Medicine

 

Commentary on Twitter

 


Two large clinical trials showed Vitamin D supplements do not reduce the risk of Covid-19.

11 Sep, 2022 | 22:56h | UTC

Study 1: Effect of a test-and-treat approach to vitamin D supplementation on risk of all cause acute respiratory tract infection and covid-19: phase 3 randomised controlled trial (CORONAVIT) – The BMJ

Study 2: Prevention of covid-19 and other acute respiratory infections with cod liver oil supplementation, a low dose vitamin D supplement: quadruple blinded, randomised placebo controlled trial – The BMJ

Editorial: Can vitamin D protect against covid-19? – The BMJ

News Release: No link between vitamin D supplements and reduced risk of covid-19 – BMJ Newsroom

 


Cohort Study | Long-term cardiac pathology in individuals with mild initial COVID-19 illness.

8 Sep, 2022 | 14:44h | UTC

Long-term cardiac pathology in individuals with mild initial COVID-19 illness – Nature Medicine

 


Review | COVID-19 in children.

8 Sep, 2022 | 14:43h | UTC

COVID-19 in Children – Pediatric Clinics of North America

 


Consensus Statement | Cardiac screening prior to return to play after SARS-CoV-2 infection in the child and adolescent athlete. – “Asymptomatic individuals and those with mild symptoms should be cleared by their primary care or team physician, after physical examination and accurate evaluation of medical history”.

6 Sep, 2022 | 14:36h | UTC

Cardiac screening prior to return to play after SARS-CoV-2 infection: focus on the child and adolescent athlete: A Clinical Consensus Statement of the Task Force for Childhood Health of the European Association of Preventive Cardiology

 


M-A | Safety and efficacy of abacavir for treating infants, children, and adolescents living with HIV.

6 Sep, 2022 | 14:27h | UTC

Safety and efficacy of abacavir for treating infants, children, and adolescents living with HIV: a systematic review and meta-analysis – The Lancet Child & Adolescent Health

 

Commentary on Twitter

 


Perspective | Science, competing values, and trade-offs in public health — the example of Covid-19 and masking.

5 Sep, 2022 | 14:37h | UTC

Science, Competing Values, and Trade-offs in Public Health — The Example of Covid-19 and Masking – New England Journal of Medicine

 


FDA authorizes updated COVID boosters from Moderna and Pfizer.

5 Sep, 2022 | 14:36h | UTC

FDA authorizes updated COVID boosters from Moderna and Pfizer – CIDRAP

FDA News Release: Coronavirus (COVID-19) Update: FDA Authorizes Moderna, Pfizer-BioNTech Bivalent COVID-19 Vaccines for Use as a Booster Dose – U.S. Food & Drug Administration

 


Review | Covid-19 vaccines — immunity, variants, boosters.

1 Sep, 2022 | 11:57h | UTC

Covid-19 Vaccines — Immunity, Variants, Boosters – New England Journal of Medicine

 


Risk of BA.5 infection among persons exposed to previous SARS-CoV-2 variants.

1 Sep, 2022 | 11:56h | UTC

Risk of BA.5 Infection among Persons Exposed to Previous SARS-CoV-2 Variants – New England Journal of Medicine

 

Commentary on Twitter

 


RCT | Outpatient convalescent plasma therapy for high-risk patients with early COVID-19.

31 Aug, 2022 | 11:48h | UTC

Outpatient convalescent plasma therapy for high-risk patients with early COVID-19. A randomized placebo-controlled trial – Clinical Microbiology and Infection

 


#ESCCongress | In critically ill patients with COVID-19, full-dose anticoagulation reduced thrombotic events but increased the risk of bleeding.

30 Aug, 2022 | 12:12h | UTC

Anticoagulation and Antiplatelet Therapy for Prevention of Venous and Arterial Thrombotic Events in Critically Ill Patients with COVID-19: COVID-PACT – Circulation

News Release: Trial supports full-dose anticoagulation to prevent blood clots in COVID-19 patients – European Society of Cardiology

Related:

Anticoagulants for people hospitalised with COVID‐19 – Cochrane Library

Anticoagulation in Patients With COVID-19: JACC Review Topic of the Week – Journal of the American College of Cardiology

Efficacy and safety of heparin full-dose anticoagulation in hospitalized non-critically ill COVID-19 patients: a meta-analysis of multicenter randomized controlled trials – Journal of Thrombosis and Thrombolysis

Efficacy and safety of intensified versus standard prophylactic anticoagulation therapy in patients with Covid-19: a systematic review and meta-analysis – Open Forum Infectious Diseases

Point/Counterpoint: Should therapeutic heparin be administered to acutely ill hospitalized patients with COVID-19?

 

Commentary on Twitter

 


Retrospective Cohort Study | Nirmatrelvir use and severe Covid-19 outcomes during the Omicron surge.

25 Aug, 2022 | 12:08h | UTC

Nirmatrelvir Use and Severe Covid-19 Outcomes during the Omicron Surge – New England Journal of Medicine

 

Commentary on Twitter

 


Retrospective Cohort Study | Clinical and genetic risk factors for acute incident venous thromboembolism in ambulatory patients with COVID-19.

24 Aug, 2022 | 14:17h | UTC

Clinical and Genetic Risk Factors for Acute Incident Venous Thromboembolism in Ambulatory Patients With COVID-19 – JAMA Internal Medicine

 

Commentary on Twitter

 


Retrospective Cohort Study | Association of COVID-19 vs. Influenza with risk of arterial and venous thrombotic events among hospitalized patients.

24 Aug, 2022 | 14:16h | UTC

Association of COVID-19 vs Influenza With Risk of Arterial and Venous Thrombotic Events Among Hospitalized Patients – JAMA

Commentary: Higher risk of vein blood clots in COVID vs flu patients – CIDRAP

News Release: People with Severe COVID-19 Face Increased Risk of Life-Threatening Blood Clots – Penn Medicine News

 

Commentary on Twitter

 


Updated systematic review and critical appraisal: prediction models for diagnosis and prognosis of covid-19.

23 Aug, 2022 | 13:31h | UTC

Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal – The BMJ

Commentary: Update to living systematic review on prediction models for diagnosis and prognosis of covid-19 – The BMJ

 

Commentary on Twitter

 


Risk of myocarditis after sequential doses of COVID-19 vaccine vs. after SARS-CoV-2 infection by age and sex.

23 Aug, 2022 | 13:25h | UTC

Risk of Myocarditis After Sequential Doses of COVID-19 Vaccine and SARS-CoV-2 Infection by Age and Sex – Circulation

News Release: Myocarditis risk significantly higher after COVID-19 infection vs. after a COVID-19 vaccine – Circulation

 


M-A | Incubation period of COVID-19 caused by unique SARS-CoV-2 strains.

23 Aug, 2022 | 13:24h | UTC

Incubation Period of COVID-19 Caused by Unique SARS-CoV-2 Strains: A Systematic Review and Meta-analysis – JAMA Network Open

 


Guideline Summary | Recommendations for the outpatient drug treatment of patients with COVID-19.

22 Aug, 2022 | 12:25h | UTC

Recommendations for the Outpatient Drug Treatment of Patients With COVID-19 – Deutsches Ärzteblatt International

 


Stay Updated in Your Specialty

No spam, just news.